CCLD CareCloud Inc

$CCLD this is getting attractive again. I’ve traded this stock for 8 years and it feel like a good time to go long. Really cheap valuation. They have the cash flow to pay down some debt or make more acquisitions

$CCLD Took my gains on this from $1.70 and rolled it all into $OLN which has also gotten decimated far beyond fair value in this crazy market.

$CCLD okay, I want it hold 2.50 now…preferable 2.52 specifically but can’t be too cute either…

$CCLD Technical analysis. CCLD surpassed MA 200 at $2.46 per share. This fact along with the big gaps from $1.80 to $2.60 will lead to a correction in the next days or weeks before the next leg up...The gaps always close....

One $CCLD metric I’m watching: recurring technology-enabled revenue reached $24M in Q2—75% of total revenue, versus 69% a year earlier. Can that mix keep improving while acquisitions are integrated? Durable recurring revenue matters more to me than a one-quarter surprise. Not financial advice.

$CCLD needed this dip to 2.30’s…needs to hold 2.30’s and finish day in mid to high 2.40’s Let’s see what happens!

$CCLD if the stock trades at enterprise value to stock price of 0.9x Grok says “Public healthcare technology medians sit around 2.1–2.8x EV/Sales. At these levels, CCLD would trade in the $5–8 range.” Looking ahead there ultimately will be 46m shares outstanding when the CEO redeems warrants at $5, revenue should be $135M+ for 2027 and at least a debt drawdown of $15M . Estimate of take out looks to be between $8.50 and $13.00 (2.5-3.2x).

$CCLD margins: adj. EBITDA margin 29%. GAAP operating margin 19.5% vs 10.3% a year ago. Revenue less direct costs at 50.5% of revenue, up from 47.8%. Mix shifting to higher-margin work.

$CCLD Nice earnings and good financials with little to no risk of dilution with positive cashflow. Blue skies to 2.60 to 2.8 from here.

$CCLD entered Q3 with FY26 guidance of $128M-$132M revenue, $29M-$31M adjusted EBITDA, and $0.20-$0.23 GAAP EPS. After $63.2M revenue and $11.3M adjusted EBITDA in H1, the second-half ramp is the key story. Reaffirming would support the execution case; raising would be even better. NFA.

$CCLD Started to nibble on the commons now . We will get a sense of how hard they've been working that ATM at the next earnings. They guided 0.2ish in EPS for 2026. The company isn't growing fast enough but if the acquisitions start contributing and they hit their marks then this is clearly undervalued on a mutliple basis now that the preferred shares are largely cleared out.

$CCLD has posted nine straight quarters of GAAP profitability. Q2 revenue was USD 31.9M, up 16% YoY. That combination is rare in a healthcare software name trading around USD 2. Q3 reports Nov 5, before the open.

$CCLD It looks like we got that perfect kiss at 2.52 this morning and bounced as expected. The plan is still working so far…I hold

$CCLD boomshockalocka! 💥💥💥 loving this move, glad i loaded all the way down as it makes it easy to scale out on a launch like this. Got plenty more to offload so keep on trucking CCLD 💪👍

$CCLD really strong day ..2.30’s are always tough …..but once we are through it’s pretty quick to the 2.50’s/2.60 area If I had to pick one number today, after the Q3 results and without assuming any takeover or aggressive peer rerating, I’d use about $3.75/share. That’s roughly 63% above $2.30, yet it still values CCLD at less than half the EBITDA multiple of major peers Let’s see what happens!!!

$CCLD Bullish — continuation watch for Monday 👀 Why: Q3 earnings beat — a record quarter, and Friday's tape closed strong. Let's see what's next!

$CCLD reports Q3 before the open Thursday, call at 8:30am ET. Last print: revenue USD 31.9M, up 16% YoY, ninth straight quarter of positive GAAP net income.

$CCLD the P/E with a conservative view should be closer to $4 than $2….and thats a pretty conservative view…reasonable ( not at all bullish view) would be $5-6 Net net we are at a huge upside precipice..hence the significant increase in institutional investment at these depressed prices We get 1 or 2 new analysts on board with 5-7$ or more forecasts and we double from here easy Let’s see what happens!

$CCLD Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.14 up 40.00% YoY • Reported revenue of $33.73M up 8.56% YoY • CareCloud reaffirmed its full-year guidance for the fiscal year ending December 31, 2026: revenue of $128.13B, adjusted EBITDA of $2.93B, and GAAP net income per share (EPS) of $0.20$0.23.

$CCLD Bought back into the common stock on this one today. Haven't owned it in a while, since the last time it came to the low $1's and swung it out in the $3's. Getting too cheap again as small caps get beat up and this baby gets thrown out with the bathwater. They paid off all the preferreds, no overhang there, and have minimal debt and way too cheap for their sales and growth given their tech stack. I honestly think that in an industry full of M&A , this team that targets cheap companies to take over might very well find themselves the target trading at these cheap prices. They had an offer once for around $350 Million but didn't take it given the preferred overhang woulda eaten up alot of it. That's not a problem anymore...